Strengthening vaccine confidence during the COVID-19 pandemic: A new opportunity for global hepatitis B virus elimination

The SARS-CoV-2 virus responsible for the ongoing COVID-19 pandemic is expected to circulate for a long time to come and may even become endemic. Until an effective vaccine against the virus is developed, which could take years if it is achieved at all, our lives will be marked by the possibility of infection despite adopting measures to help diminish risk. As a result, the sudden public and policy focus on the broad and rapid benefits of vaccination for COVID-19 is unsurprising, and it would be remiss not to examine how this interest can be applied to improve vaccine coverage for other viruses, such as hepatitis B virus (HBV).